CN1834093A - Synthesis method of chiral 2-amino-1- (6-fluoro-3, 4-dihydrobenzopyranyl) ethanol - Google Patents
Synthesis method of chiral 2-amino-1- (6-fluoro-3, 4-dihydrobenzopyranyl) ethanol Download PDFInfo
- Publication number
- CN1834093A CN1834093A CN 200510011446 CN200510011446A CN1834093A CN 1834093 A CN1834093 A CN 1834093A CN 200510011446 CN200510011446 CN 200510011446 CN 200510011446 A CN200510011446 A CN 200510011446A CN 1834093 A CN1834093 A CN 1834093A
- Authority
- CN
- China
- Prior art keywords
- fluoro
- dihydrobenzopyrans base
- ethanol
- hours
- amido
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- XEWOKAJCYBGRTK-UHFFFAOYSA-N 2-amino-1-(6-fluoro-3,4-dihydro-2h-chromen-2-yl)ethanol Chemical compound FC1=CC=C2OC(C(O)CN)CCC2=C1 XEWOKAJCYBGRTK-UHFFFAOYSA-N 0.000 title 1
- 238000001308 synthesis method Methods 0.000 title 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 53
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 claims abstract description 30
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims abstract description 18
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims abstract description 17
- 238000000034 method Methods 0.000 claims abstract description 12
- 239000002904 solvent Substances 0.000 claims abstract description 11
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 238000010189 synthetic method Methods 0.000 claims abstract description 9
- 238000010992 reflux Methods 0.000 claims abstract description 7
- 150000002148 esters Chemical class 0.000 claims description 27
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 26
- 238000006243 chemical reaction Methods 0.000 claims description 23
- 239000007787 solid Substances 0.000 claims description 21
- 238000010025 steaming Methods 0.000 claims description 19
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 18
- YXFVVABEGXRONW-UHFFFAOYSA-N toluene Substances CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 18
- 238000003756 stirring Methods 0.000 claims description 17
- 238000000605 extraction Methods 0.000 claims description 15
- 238000005406 washing Methods 0.000 claims description 13
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- 229910000497 Amalgam Inorganic materials 0.000 claims description 9
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 9
- 239000011701 zinc Substances 0.000 claims description 9
- 229910052725 zinc Inorganic materials 0.000 claims description 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 8
- 230000001476 alcoholic effect Effects 0.000 claims description 8
- 229910021529 ammonia Inorganic materials 0.000 claims description 8
- 238000001953 recrystallisation Methods 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 8
- 238000001816 cooling Methods 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 6
- GVOISEJVFFIGQE-YCZSINBZSA-N n-[(1r,2s,5r)-5-[methyl(propan-2-yl)amino]-2-[(3s)-2-oxo-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-1-yl]cyclohexyl]acetamide Chemical compound CC(=O)N[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1C(=O)[C@@H](NC=2C3=CC(=CC=C3N=CN=2)C(F)(F)F)CC1 GVOISEJVFFIGQE-YCZSINBZSA-N 0.000 claims description 6
- 229910052760 oxygen Inorganic materials 0.000 claims description 6
- 239000001301 oxygen Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- HBENZIXOGRCSQN-VQWWACLZSA-N (1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-16-[(2S)-2-hydroxy-3,3-dimethylpentan-2-yl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol Chemical compound N1([C@@H]2CC=3C4=C(C(=CC=3)O)O[C@H]3[C@@]5(OC)CC[C@@]2([C@@]43CC1)C[C@@H]5[C@](C)(O)C(C)(C)CC)CC1CC1 HBENZIXOGRCSQN-VQWWACLZSA-N 0.000 claims description 4
- YLEIFZAVNWDOBM-ZTNXSLBXSA-N ac1l9hc7 Chemical compound C([C@H]12)C[C@@H](C([C@@H](O)CC3)(C)C)[C@@]43C[C@@]14CC[C@@]1(C)[C@@]2(C)C[C@@H]2O[C@]3(O)[C@H](O)C(C)(C)O[C@@H]3[C@@H](C)[C@H]12 YLEIFZAVNWDOBM-ZTNXSLBXSA-N 0.000 claims description 4
- 239000012074 organic phase Substances 0.000 claims description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 4
- 239000011259 mixed solution Substances 0.000 claims description 3
- 238000005554 pickling Methods 0.000 claims description 3
- 150000003233 pyrroles Chemical class 0.000 claims description 3
- SRVFFFJZQVENJC-IHRRRGAJSA-N aloxistatin Chemical compound CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C SRVFFFJZQVENJC-IHRRRGAJSA-N 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims 2
- 238000001914 filtration Methods 0.000 claims 1
- 239000002994 raw material Substances 0.000 abstract description 4
- 238000006214 Clemmensen reduction reaction Methods 0.000 abstract description 2
- 238000010511 deprotection reaction Methods 0.000 abstract description 2
- 238000006722 reduction reaction Methods 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- -1 4-dihydrobenzopyranyl Chemical group 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 238000001035 drying Methods 0.000 description 12
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- 239000000706 filtrate Substances 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 239000012450 pharmaceutical intermediate Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003810 ethyl acetate extraction Methods 0.000 description 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention belongs to the field of organic chemistry, and particularly relates to a synthetic method of a drug intermediate -2-amino-1- ( -6-fluoro-3, 4-dihydrobenzopyranyl) ethanol and -2-amino-1- ((S) -6-fluoro-3, 4-dihydrobenzopyranyl) ethanol. The method adopts a drug intermediate (2R) -2- [ (1R) -4, 4-dimethyl-3, 5-dihydrooxocyclopentyl ] -6-fluorobenzo-dihydropyran-4-ketone and (2S) -2- [ (1R) -4, 4-dimethyl-3, 5-dihydrooxocyclopentyl ] -6-fluorobenzo-dihydropyran-4-ketone as raw materials, products obtained by one-step reduction and deprotection by a Clemmensens method respectively react with p-toluenesulfonyl chloride in pyridine, the obtained products are respectively dissolved in a solvent, and then dry ammonia gas is introduced for heating and refluxing. The total yield can reach 32 percent.
Description
Technical field
The invention belongs to organic chemistry filed, specially refer to pharmaceutical intermediate (R)-2-amido-1-((R)-6-fluoro-3,4-dihydrobenzopyrans base) ethanol, (R)-2-amido-1-((S)-6-fluoro-3,4-dihydrobenzopyrans base) alcoholic acid synthetic method.
Background technology
(R)-2-amido-1-((R)-6-fluoro-3,4-dihydrobenzopyrans base) ethanol, (R)-2-amido-1-((S)-6-fluoro-3,4-dihydrobenzopyrans base) ethanol are the important intermediate of biomedical bioactive molecule.Their synthetic method has had report in " tetrahedron ".At first after reactions such as Sharpless chiral epoxy, make chipal compounds (R)-1-((R)-6-fluoro-3,4-dihydrobenzopyrans base) ethane-1,2-glycol (as shown in the formula described 2a), (S)-1-((R)-6-fluoro-3,4-dihydrobenzopyrans base) ethane-1,2-glycol (as shown in the formula described 2b), generate p-toluenesulfonic esters with the Tosyl chloride reaction then, follow and reaction of sodium azide, hydrogenation obtains compound (R)-2-amido-1-((R)-6-fluoro-3,4-dihydrobenzopyrans base) ethanol (as shown in the formula described 4a), (R)-2-amido-1-((S)-6-fluoro-3,4-dihydrobenzopyrans base) ethanol (as shown in the formula described 4b).This synthetic method route is long, productive rate is low, and separates to purify and utilize post to separate mostly, and the conditional request harshness during reaction reacts restive, and total recovery is low, can't produce in batches.
Summary of the invention
It is too much to the objective of the invention is to overcome the reactions steps that exists in the prior art, the operation complexity, the conditional request harshness, product purity is low, raw material reagent costs an arm and a leg, production cost is too high, yield is low, produce problems such as difficulty in batches, a kind of reaction conditions gentleness is provided, easy and simple to handle, synthetic route is short, synthetic cost is low, yield height, (R)-2-amido-1-((R)-6-fluoro-3 that suitable batch is produced, 4-dihydrobenzopyrans base) ethanol (as shown in the formula described 4a), (R)-new synthetic method of 2-amido-1-((S)-6-fluoro-3,4-dihydrobenzopyrans base) ethanol (as shown in the formula described 4b).
The synthetic route of (R)-2-amido-1-provided by the invention ((R)-6-fluoro-3,4-dihydrobenzopyrans base) ethanol (4a), (R)-2-amido-1-((S)-6-fluoro-3,4-dihydrobenzopyrans base) ethanol (4b) is:
(1a) described in the present invention, (1b), (2a), (2b), (3a), (3b), (4a), (4b), 1a, 1b, 2a, 2b, 3a, 3b, 4a, 4b, corresponding to 1a, 1b, 2a, 2b, 3a, 3b, 4a, the 4b described in the top synthetic route, wherein, R represents dextrorotation, and the S representative is left-handed.
Chirality 2-amido-1-of the present invention (6-fluoro-3,4-dihydrobenzopyrans base) alcoholic acid synthetic method may further comprise the steps:
(1). in reaction vessel, compound 1a or 1b are mixed with freshly prepd zinc amalgam and solvent hydrochloric acid and etoh solvent, temperature of reaction is controlled at 20～60 ℃, reacted 24～72 hours, and then added solvent hydrochloric acid reflux 3～20 hours, cooling, filter, extraction, washing, dry organic phase, revolve to steam and obtain thick liquid, utilize ethyl acetate, the mixed solution recrystallization of sherwood oil or ethyl acetate and sherwood oil, obtain the white solid of 2a or 2b respectively, wherein the mol ratio of compound 1a or 1b and freshly prepd zinc amalgam is 1: 100 to 1: 150;
(2). compound 2a that step (1) is obtained or 2b are with the pyridine or the dissolving of pyrroles's solution of Tosyl chloride, stir, be cooled to-10～20 ℃, maintain the temperature at-10～20 ℃, reacted 24～72 hours, add frozen water then, extraction, pickling, wash neutral, dry, revolve to steam and obtain solid, mixed solution recrystallization with ethyl acetate, sherwood oil or ethyl acetate and sherwood oil, obtain 3a or 3b white solid respectively, wherein the mol ratio of compound 2a or 2b and Tosyl chloride is 1: 0.9 to 1: 1.5;
(3). 3a or 3b that step (2) is obtained are dissolved in respectively in methyl alcohol or the alcohol solvent, stir, feed the exsiccant ammonia, reflux 2～24 hours, cool off, revolve steaming, dissolve with sodium hydroxide solution, extraction, washing, dry organic phase, revolve to steam and obtain solid, with ether or tetrahydrofuran (THF) recrystallization, obtain compound (R)-2-amido-1-((R)-6-fluoro-3 respectively, 4-dihydrobenzopyrans base) alcoholic acid white solid, or (R)-2-amido-1-((S)-6-fluoro-3,4-dihydrobenzopyrans base) alcoholic acid white solid.
The solvent of described step (2) is pyridine or pyrroles etc.
Described 1a is (2R)-2-[(1R)-4,4-dimethyl-3,5-two assorted oxygen cyclopentyl]-6-fluorobenzene and dihydropyrane-4-ketone.
Described 1b is (2S)-2-[(1R)-4,4-dimethyl-3,5-two assorted oxygen cyclopentyl]-6-fluorobenzene and dihydropyrane-4-ketone.
Described 2a is (R)-1-((R)-6-fluoro-3,4-dihydrobenzopyrans base) ethane-1, the 2-glycol.
Described 2b is (S)-1-((R)-6-fluoro-3,4-dihydrobenzopyrans base) ethane-1, the 2-glycol.
Described 3a is (R)-2-((R)-6-fluoro-3,4-dihydrobenzopyrans base)-2-hydroxyethyl-4-toluene sulfonic acide ester.
Described 3b is (R)-2-((S)-6-fluoro-3,4-dihydrobenzopyrans base)-2-hydroxyethyl-4-toluene sulfonic acide ester.
The used acid of described pickling can be dilute hydrochloric acid etc.
The present invention adopts pharmaceutical intermediate (2R)-2-[(1R)-4; 4-dimethyl-3; 5-two assorted oxygen cyclopentyl]-6-fluorobenzene and dihydropyrane-4-ketone (1a); (2S)-2-[(1R)-4; 4-dimethyl-3; the assorted oxygen cyclopentyl of 5-two]-6-fluorobenzene and dihydropyrane-4-ketone (1b) are raw material; utilize Clemmensens method one step reduction deprotection to obtain (R)-1-((R)-6-fluoro-3 respectively; 4-dihydrobenzopyrans base) ethane-1; 2-glycol (2a); (S)-1-((R)-6-fluoro-3; 4-dihydrobenzopyrans base) ethane-1; 2-glycol (2b); 2a and 2b obtain (R)-2-((R)-6-fluoro-3 with the Tosyl chloride reaction respectively in pyridine; 4-dihydrobenzopyrans base)-2-hydroxyethyl-4-toluene sulfonic acide ester (3a); (R)-2-((S)-6-fluoro-3,4-dihydrobenzopyrans base)-2-hydroxyethyl-4-toluene sulfonic acide ester (3b).3a and 3b are dissolved in the solvent respectively, feed exsiccant ammonia reflux then and obtain (R)-2-amido-1-((R)-6-fluoro-3,4-dihydrobenzopyrans base) ethanol (4a), (R)-2-amido-1-((S)-6-fluoro-3,4-dihydrobenzopyrans base) ethanol (4b) obtains two kinds of solid pure substances.Of the present invention method is simple, and reaction conditions gentleness in the building-up process utilizes cheap ammonia to reduce reactions steps for raw material has reduced cost, and separation method is easy, the purification technique maturation, and total recovery can reach 32%.
Embodiment
The invention will be further described below by example.
Embodiment 1
(1). (R)-1-((R)-6-fluoro-3,4-dihydrobenzopyrans base) ethane-1,2-glycol (2a) synthetic:
In reactor, add compound 1a and freshly prepd zinc amalgam (mol ratio, 1: 120), hydrochloric acid (40ml), 48ml ethanol, stirring reaction 50 hours, and then add hydrochloric acid (20ml), reacted cooling 6 hours, filter, use ethyl acetate extraction filtrate, saturated common salt is washed to neutrality, anhydrous sodium sulfate drying filters, and revolves steaming, obtain heavy-gravity liquid (R)-1-((R)-6-fluoro-3,4-dihydrobenzopyrans base) ethane-1,2-glycol (2a).
(2). (R)-2-((R)-6-fluoro-3,4-dihydrobenzopyrans base)-2-hydroxyethyl-4-toluene sulfonic acide ester (3a) synthetic:
In reactor, add (R)-1-((R)-6-fluoro-3,4-dihydrobenzopyrans base) ethane-1,2-glycol (2a) adds the dissolving of 10ml pyridine, stir, add Tosyl chloride (mol ratio, 2a: Tosyl chloride=1: 1.0), reacted 48 hours then, then, add the 10ml frozen water to reaction system, extraction, dilute hydrochloric acid is washed, the saturated common salt washing, anhydrous sodium sulfate drying filters, and revolves steaming, get thick liquid (R)-2-((R)-6-fluoro-3,4-dihydrobenzopyrans base)-2-hydroxyethyl-4-toluene sulfonic acide ester (3a).
(3). (R)-2-amido-1-((R)-6-fluoro-3,4-dihydrobenzopyrans base) ethanol (4a) synthetic:
In reactor, add 1.5g (R)-2-((R)-6-fluoro-3,4-dihydrobenzopyrans base)-2-hydroxyethyl-4-toluene sulfonic acide ester (3a), the 20ml dissolve with methanol stirs, and feeds the exsiccant ammonia, reacted 5 hours, and revolved steaming, obtain solid, with sodium hydroxide solution dissolving, extraction, washing, the Anhydrous potassium carbonate drying is filtered, and revolves steaming, obtain solid (R)-2-amido-1-((R)-6-fluoro-3,4-dihydrobenzopyrans base) ethanol (4a).
Embodiment 2
(1). (R)-1-((R)-6-fluoro-3,4-dihydrobenzopyrans base) ethane-1,2-glycol (2a) synthetic:
In reactor, add compound 1a, freshly prepd zinc amalgam (mol ratio, 1a: zinc amalgam=1: 1.2), 60ml hydrochloric acid, 48ml ethanol, stirring reaction 46 hours, and then add 30ml hydrochloric acid, reacted cooling 6 hours, filter, extraction filtrate, saturated common salt is washed to neutrality, anhydrous sodium sulfate drying filters, and revolves steaming, obtain heavy-gravity liquid (R)-1-((R)-6-fluoro-3,4-dihydrobenzopyrans base) ethane-1,2-glycol (2a).
(2). (R)-2-((R)-6-fluoro-3,4-dihydrobenzopyrans base)-2-hydroxyethyl-4-toluene sulfonic acide ester (3a) synthetic:
In reactor, add (R)-1-((R)-6-fluoro-3,4-dihydrobenzopyrans base) ethane-1,2-glycol (2a) adds the dissolving of 15ml pyridine, stirs, add Tosyl chloride (mol ratio then, 2a: Tosyl chloride=1: 1.4), stirring reaction 24 hours adds the 10ml frozen water to reaction system, use extracted with diethyl ether, Diluted Acid Washing, saturated common salt washing, anhydrous sodium sulfate drying, filter, revolve steaming, get thick liquid (R)-2-((R)-6-fluoro-3,4-dihydrobenzopyrans base)-2-hydroxyethyl-4-toluene sulfonic acide ester (3a).
(3). (R)-2-amido-1-((R)-6-fluoro-3,4-dihydrobenzopyrans base) ethanol (4a) synthetic:
In reactor, add 1.2g (R)-2-((R)-6-fluoro-3,4-dihydrobenzopyrans base)-2-hydroxyethyl-4-toluene sulfonic acide ester (3a), the 20ml dissolve with methanol stirs, and feeds ammonia, reacted 6 hours, and revolved steaming and obtain solid, dissolve with sodium hydroxide solution, extraction, washing, Anhydrous potassium carbonate drying, filter, revolve steaming, obtain solid (R)-2-amido-1-((R)-6-fluoro-3,4-dihydrobenzopyrans base) ethanol (4a).
Embodiment 3
(1). (S)-1-((R)-6-fluoro-3,4-dihydrobenzopyrans base) ethane-1,2-glycol (2b) synthetic:
In reactor, add compound and freshly prepd zinc amalgam (mol ratio, 1: 110), 90ml hydrochloric acid, 48ml ethanol, stirring reaction 50 hours, and then adding dilute hydrochloric acid, reacted cooling 6 hours, filter, extraction filtrate, saturated common salt is washed to neutrality, anhydrous sodium sulfate drying filters, and revolves steaming, obtain heavy-gravity liquid (S)-1-((R)-6-fluoro-3,4-dihydrobenzopyrans base) ethane-1, the 2-glycol.
(2). (R)-2-((S)-6-fluoro-3,4-dihydrobenzopyrans base)-2-hydroxyethyl-4-toluene sulfonic acide ester (3b) synthetic:
In reactor, add (S)-1-((R)-6-fluoro-3,4-dihydrobenzopyrans base) ethane-1,2-glycol (2b) adds the pyridine dissolving, stirs, add Tosyl chloride (mol ratio then, 2b: Tosyl chloride=1: 1.01), stirred 24 hours, add 10ml frozen water termination reaction to reaction system then, extraction, dilute hydrochloric acid is washed, saturated common salt washing, anhydrous sodium sulfate drying, filter, revolve steaming, get thick liquid (R)-2-((S)-6-fluoro-3,4-dihydrobenzopyrans base)-2-hydroxyethyl-4-toluene sulfonic acide ester.
(3). (R)-2-amido-1-((S)-6-fluoro-3,4-dihydrobenzopyrans base) ethanol (4b) synthetic:
In reactor, add 1.6g (R)-2-((S)-6-fluoro-3,4-dihydrobenzopyrans base)-2-hydroxyethyl-4-toluene sulfonic acide ester (3b) and dissolve with methanol, stir, feed ammonia, reacted 7 hours, revolve to steam and obtain solid, with sodium hydroxide solution dissolving, extraction, washing, the Anhydrous potassium carbonate drying, filter, revolve steaming, (R)-2-amido-1-((S)-6-fluoro-3,4-dihydrobenzopyrans base) ethanol (4b) that obtains solid.
Embodiment 4
(1) (S)-and 1-((R)-6-fluoro-3,4-dihydrobenzopyrans base) ethane-1,2-glycol (2b) synthetic:
In reactor, add compound and freshly prepd zinc amalgam (mol ratio, 1: 135), 80ml hydrochloric acid, 48ml ethanol at 25 ℃, reacted 50 hours, and then add 40ml dilute hydrochloric acid, reacted cooling 6 hours, filter, extraction filtrate, saturated common salt is washed to neutrality, anhydrous sodium sulfate drying filters, and revolves steaming, obtain heavy-gravity liquid (S)-1-((R)-6-fluoro-3,4-dihydrobenzopyrans base) ethane-1, the 2-glycol.
(2) (R)-2-((S)-6-fluoro-3,4-dihydrobenzopyrans base)-2-hydroxyethyl-4-toluene sulfonic acide ester (3b) synthetic:
In reactor, add (S)-1-((R)-6-fluoro-3,4-dihydrobenzopyrans base) ethane-1,2-glycol (2b) adds the dissolving of 15ml pyridine, stirs, add Tosyl chloride (mol ratio then, 2b: Tosyl chloride=1: 1.15), stirring reaction 48 hours adds the 10ml frozen water to reaction system, use extracted with diethyl ether, dilute hydrochloric acid is washed, saturated common salt washing, anhydrous sodium sulfate drying, filter, revolve steaming, get thick liquid (R)-2-((S)-6-fluoro-3,4-dihydrobenzopyrans base)-2-hydroxyethyl-4-toluene sulfonic acide ester (3b).
(3). (R)-2-amido-1-((S)-6-fluoro-3,4-dihydrobenzopyrans base) ethanol (4b) synthetic:
In reactor, add 1.8g (R)-2-((S)-6-fluoro-3,4-dihydrobenzopyrans base)-2-hydroxyethyl-4-toluene sulfonic acide ester (3b), the 30ml dissolve with methanol stirs, and feeds ammonia, reacted 9 hours, steaming is revolved in cooling, obtain solid, with sodium hydroxide solution dissolving, extraction, washing, the Anhydrous potassium carbonate drying is filtered, revolve steaming, obtain solid (R)-2-amido-1-((S)-6-fluoro-3,4-dihydrobenzopyrans base) ethanol (4b).
Claims (8)
1. a chirality 2-amido-1-(6-fluoro-3,4-dihydrobenzopyrans base) alcoholic acid synthetic method, it is characterized in that: the step of described synthetic method comprises:
(1). in reaction vessel, compound 1a or 1b are mixed with freshly prepd zinc amalgam and solvent hydrochloric acid and ethanol, temperature of reaction is controlled at 20～60 ℃, and then adding solvent hydrochloric acid and reflux, cooling, filtration, extraction, washing, dry organic phase, revolve steaming, obtain thick liquid, recrystallization, obtain the white solid of 2a or 2b respectively, wherein the mol ratio of compound 1a or 1b and freshly prepd zinc amalgam is 1: 100 to 1: 150;
(2). compound 2a that step (1) is obtained or 2b are with the pyridine or the dissolving of pyrroles's solution of Tosyl chloride, stir, be cooled to-10～20 ℃, maintain the temperature at-10～20 ℃, add frozen water then, extraction, pickling, wash neutrally, dry, revolve steaming, obtain solid, recrystallization obtains 3a or 3b white solid respectively, wherein the mol ratio of compound 2a or 2b and Tosyl chloride be 1: 0.9 to 1.5;
(3). 3a or 3b that step (2) is obtained are dissolved in the solvent respectively, stir, feed the exsiccant ammonia, reflux is cooled off, is revolved steaming, dissolves with sodium hydroxide solution, extraction, washing, dry organic phase, revolve to steam and obtain solid, recrystallization obtains compound (R)-2-amido-1-((R)-6-fluoro-3,4-dihydrobenzopyrans base) alcoholic acid white solid respectively, or (R)-2-amido-1-((S)-6-fluoro-3,4-dihydrobenzopyrans base) alcoholic acid white solid;
Described 1a is (2R)-2-[(1R)-4,4-dimethyl-3,5-two assorted oxygen cyclopentyl]-6-fluorobenzene and dihydropyrane-4-ketone;
Described 1b is (2S)-2-[(1R)-4,4-dimethyl-3,5-two assorted oxygen cyclopentyl]-6-fluorobenzene and dihydropyrane-4-ketone;
Described 2a is (R)-1-((R)-6-fluoro-3,4-dihydrobenzopyrans base) ethane-1, the 2-glycol;
Described 2b is (S)-1-((R)-6-fluoro-3,4-dihydrobenzopyrans base) ethane-1, the 2-glycol;
Described 3a is (R)-2-((R)-6-fluoro-3,4-dihydrobenzopyrans base)-2-hydroxyethyl-4-toluene sulfonic acide ester;
Described 3b is (R)-2-((S)-6-fluoro-3,4-dihydrobenzopyrans base)-2-hydroxyethyl-4-toluene sulfonic acide ester.
2. method according to claim 1 is characterized in that: the reaction times of described step (1) is 24～72 hours.
3. method according to claim 1 is characterized in that: the reflux of described step (1) is 3～20 hours.
4. method according to claim 1 is characterized in that: the reaction times of described step (2) is 24～72 hours.
5. method according to claim 1 is characterized in that: described step (1) or step (2) are with ethyl acetate, sherwood oil, or the mixed solution recrystallization of ethyl acetate and sherwood oil.
6. method according to claim 1 is characterized in that: the reflux of described step (3) is 2～24 hours.
7. method according to claim 1 is characterized in that: described step (3) is with ether or tetrahydrofuran (THF) recrystallization.
8. method according to claim 1 is characterized in that: the solvent of described step (3) is methyl alcohol or ethanol.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100114465A CN100387586C (en) | 2005-03-18 | 2005-03-18 | Synthesis method of chiral 2-amino-1- (6-fluoro-3, 4-dihydrobenzopyranyl) ethanol |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100114465A CN100387586C (en) | 2005-03-18 | 2005-03-18 | Synthesis method of chiral 2-amino-1- (6-fluoro-3, 4-dihydrobenzopyranyl) ethanol |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1834093A true CN1834093A (en) | 2006-09-20 |
| CN100387586C CN100387586C (en) | 2008-05-14 |
Family
ID=37002009
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100114465A Expired - Fee Related CN100387586C (en) | 2005-03-18 | 2005-03-18 | Synthesis method of chiral 2-amino-1- (6-fluoro-3, 4-dihydrobenzopyranyl) ethanol |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100387586C (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102311417A (en) * | 2010-06-29 | 2012-01-11 | 成都弘达药业有限公司 | Method for preparing benzodihydropyran compound |
| CN102344431A (en) * | 2010-08-05 | 2012-02-08 | 成都康弘药业集团股份有限公司 | Method for preparing nebivolol hydrochloride |
| JP2013209404A (en) * | 2006-11-27 | 2013-10-10 | Zach System Spa | Process for preparing nebivolol |
| US10526304B2 (en) | 2015-05-19 | 2020-01-07 | Zhejiang Ausun Pharmaceutical Co., Ltd. | Nebivolol synthesis method and intermediate compound thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4990668A (en) * | 1985-12-04 | 1991-02-05 | E. I. Du Pont De Nemours And Company | Optically active aryloxypropanolamines and arylethanolamines |
| SE9701438D0 (en) * | 1997-04-17 | 1997-04-17 | Astra Ab | A new process |
| US6903227B2 (en) * | 2000-06-02 | 2005-06-07 | Millennium Pharmaceuticals, Inc. | Synthesis of 2-acyl substituted chromanes and intermediates thereof |
| WO2002018342A2 (en) * | 2000-08-31 | 2002-03-07 | The University Of Iowa Research Foundation | Novel autoinducer molecules and uses therefor |
-
2005
- 2005-03-18 CN CNB2005100114465A patent/CN100387586C/en not_active Expired - Fee Related
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013209404A (en) * | 2006-11-27 | 2013-10-10 | Zach System Spa | Process for preparing nebivolol |
| CN102311417A (en) * | 2010-06-29 | 2012-01-11 | 成都弘达药业有限公司 | Method for preparing benzodihydropyran compound |
| CN102311417B (en) * | 2010-06-29 | 2013-09-18 | 成都弘达药业有限公司 | Method for preparing benzodihydropyran compound |
| CN102344431A (en) * | 2010-08-05 | 2012-02-08 | 成都康弘药业集团股份有限公司 | Method for preparing nebivolol hydrochloride |
| CN102344431B (en) * | 2010-08-05 | 2014-03-26 | 成都康弘药业集团股份有限公司 | Method for preparing nebivolol hydrochloride |
| US10526304B2 (en) | 2015-05-19 | 2020-01-07 | Zhejiang Ausun Pharmaceutical Co., Ltd. | Nebivolol synthesis method and intermediate compound thereof |
| US11142512B2 (en) | 2015-05-19 | 2021-10-12 | Zhejiang Ausun Pharmaceutical Co., Ltd. | Nebivolol synthesis method and intermediate compound thereof |
| EP3974419A2 (en) | 2015-05-19 | 2022-03-30 | Zhejiang Ausun Pharmaceutical Co., Ltd. | Nebivolol synthesis method and intermediate compound thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100387586C (en) | 2008-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN114315534A (en) | Preparation method of dapagliflozin intermediate | |
| CN1264372A (en) | Process for the preparation of chiral 3,4-epoxybutyric acid and the salt thereof | |
| CN1834093A (en) | Synthesis method of chiral 2-amino-1- (6-fluoro-3, 4-dihydrobenzopyranyl) ethanol | |
| CN1872841A (en) | Method for preparing Rosuvastatin Calcium and key intermediate | |
| CN1709897A (en) | Synthesis of compound 9,10-dihydro-9-oxy-10-phospha phenanthrene and purification process thereof | |
| US8912345B2 (en) | Method for preparing optically pure (−)-clausenamide compound | |
| CN1265092A (en) | Process for prepn. of L-carnitine | |
| CN104072398A (en) | Method for synthesizing ezetimibe | |
| CN1680374A (en) | Novel synthesis and crystallization of piperazine ring-containing compounds | |
| CN103183673A (en) | Synthesizing method of (S,S)-2,8-diazabicyclo[4.3.0]nonane | |
| CN1476440A (en) | Lactonization process | |
| CN112939900B (en) | Preparation method of buvaracetam intermediate | |
| CN1948264A (en) | Preparation method of alpha-acetyl substituted alpha, beta-unsaturated ester | |
| CN1974551A (en) | Process of synthesizing (2S-trans)-3-methyl-4-oxo-1-azacyclo butyl sulfonic acid | |
| CN1978442A (en) | Synthesis method of (R, R, R, S)2,2' - [ imino-di (methylene) ] bis- (6-fluoro-3, 4-dihydro-2H-1-benzopyran-2-methanol) nepyrrolel hydrochloride | |
| CN102010345A (en) | Method for preparing D-phenylalanine through dynamic kinetic resolution | |
| CN1086187C (en) | Method for preparing bicyclohexyl-18-crown-6 | |
| CN111100026A (en) | Preparation method of taxol oxazole ring side chain intermediate | |
| CN1566080A (en) | Resolution of DL-phenylalanine | |
| CN1246308C (en) | Preparation process of beta-hydroxylic sulfone derivation | |
| CN1502615A (en) | Process for preparing optical purity tetrahydrofuran-2-aminic acid | |
| CN110563627B (en) | Preparation method of (S) -1- (2-chloroacetyl) pyrrolidine-2-carbonitrile | |
| CN1220686C (en) | Beta-hydroxy-alpha-amino acid and its derivatives and synthesizing method for preparing template | |
| CN110272360B (en) | Preparation method of florfenicol reducing substance intermediate | |
| CN118546069B (en) | Process improvement method of pregabalin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080514 Termination date: 20120318 |